Treatment outcomes from primary CTCL

Amra Osmancevic, MD, PhD, University of Gothenburg, Gothenburg, Sweden, discuses the findings of a retrospective study investigating the diagnostics and treatment outcomes of patients with primary T-cell lymphoma (CTCL), reporting that most patients were treated with targeted therapies. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

• Kategorija